Sun Pharma Advanced Research Company Limited (NSE: SPARC)
225.72
+1.18 (0.53%)
Sep 6, 2024, 3:30 PM IST
SPARC Revenue
Sun Pharma Advanced Research Company had revenue of 168.10M INR in the quarter ending June 30, 2024, a decrease of -29.81%. This brings the company's revenue in the last twelve months to 684.05M, down -70.80% year-over-year. In the fiscal year ending March 31, 2024, Sun Pharma Advanced Research Company had annual revenue of 755.45M, down -68.36%.
Revenue (ttm)
684.05M
Revenue Growth
-70.80%
P/S Ratio
107.06
Revenue / Employee
1.67M
Employees
409
Market Cap
73.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2024 | 755.45M | -1.63B | -68.36% |
Mar 31, 2023 | 2.39B | 1.02B | 73.98% |
Mar 31, 2022 | 1.37B | -1.16B | -45.74% |
Mar 31, 2021 | 2.53B | 1.76B | 229.31% |
Mar 31, 2020 | 768.14M | -1.06B | -57.99% |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Mar 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Reliance Industries Limited | 9,252.89B |
Tata Consultancy Services Limited | 2,441.25B |
HDFC Bank Limited | 2,663.37B |
Bharti Airtel Limited | 1,510.49B |
ICICI Bank Limited | 1,686.78B |
Infosys Limited | 1,555.41B |
State Bank of India | 3,319.63B |
Hindustan Unilever Limited | 621.07B |